8-K: Global Payments Announces Q3 2024 Results, Sale of AdvancedMD, and $600 Million Share Repurchase
Quarterly Report
Global Payments reported solid third-quarter results, announced the sale of AdvancedMD for $1.125 billion, and initiated a $600 million accelerated share repurchase program.
Summary
- Global Payments reported its financial results for the third quarter of 2024, ending September 30, 2024.
- GAAP revenue for the quarter was $2.60 billion, a 5% increase compared to $2.48 billion in the same period last year.
- Adjusted net revenue increased by 6% to $2.36 billion, up from $2.23 billion in the third quarter of 2023.
- GAAP diluted earnings per share (EPS) decreased by 11% to $1.24, while adjusted EPS increased by 12% to $3.08.
- The company has reached a definitive agreement to sell AdvancedMD to Francisco Partners for $1.125 billion, with the transaction expected to close in the fourth quarter of 2024.
- Global Payments has also initiated a $600 million accelerated share repurchase program, with approximately five million shares expected to be received on October 31, 2024.
- The company reaffirmed its 2024 outlook, expecting adjusted net revenue to be between $9.17 billion and $9.30 billion, and adjusted EPS to be between $11.54 and $11.70.
Sentiment
Score: 7
Explanation: The sentiment is positive due to strong adjusted revenue and EPS growth, the strategic sale of AdvancedMD, and the share repurchase program. However, the decrease in GAAP EPS and operating margin tempers the overall positive outlook.
Positives
- The company demonstrated solid financial performance in the third quarter, with revenue and adjusted EPS growth.
- The sale of AdvancedMD is expected to enhance value creation for shareholders.
- The accelerated share repurchase program is a positive sign of management's confidence in the company's value.
- The company is making progress on its transformation agenda, streamlining and simplifying its business.
- Global Payments reduced its net leverage position to 3.3 times sequentially.
- The company reaffirmed its 2024 outlook, indicating consistency in its business model.
Negatives
- GAAP diluted earnings per share decreased by 11% in the third quarter.
- Operating margin decreased to 18.3% from 22.5% in the prior year.
- The company incurred significant operating expenses, including $1.179 billion in selling, general and administrative expenses.
Risks
- The sale of AdvancedMD is subject to regulatory approvals and other closing conditions, which may not be met.
- There are risks associated with the integration of acquired companies and the management of credit and fraud risks.
- The company faces risks related to security breaches, operational failures, and compliance with payment network requirements.
- Global economic conditions, foreign currency exchange rates, and rising interest rates could impact the company's performance.
- The company is exposed to risks associated with its indebtedness.
- There is a risk of potential stockholder litigation associated with the sale of AdvancedMD.
Future Outlook
Global Payments reaffirmed its 2024 outlook, expecting adjusted net revenue to grow by 6% to 7% and adjusted earnings per share to grow by 11% to 12%. The company also anticipates adjusted operating margin to expand by up to 50 basis points.
Management Comments
- Cameron Bready, chief executive officer, stated that the company is pleased with its solid financial performance in the third quarter, highlighting the resiliency of the business.
- Bready also mentioned that the company is making substantial progress on its transformation agenda, unifying the organization and streamlining the business.
- Josh Whipple, chief financial officer, noted the strong adjusted free cash flow in the third quarter and the reduction in net leverage.
- Whipple also emphasized the consistency of the company's model and the benefits of its sharpened focus.
Industry Context
This announcement comes as the payments industry continues to evolve, with companies focusing on streamlining operations and enhancing shareholder value. The sale of AdvancedMD and the share repurchase program reflect Global Payments' strategic shift towards core payment solutions and capital allocation efficiency. The company's focus on transformation and simplification aligns with broader industry trends of optimizing business models for sustainable growth.
Comparison to Industry Standards
- Global Payments' adjusted net revenue growth of 6% in Q3 2024 is comparable to peers such as Fiserv (FISV) and Fidelity National Information Services (FIS), which have also reported mid-single-digit revenue growth in recent quarters.
- The adjusted EPS growth of 12% is strong, potentially outperforming some competitors who are facing margin pressures due to increased operating costs.
- The sale of AdvancedMD for $1.125 billion is a significant divestiture, similar to other strategic asset sales seen in the industry as companies focus on core competencies.
- The $600 million accelerated share repurchase program is a common capital allocation strategy among mature payment companies, reflecting a focus on returning value to shareholders.
- Global Payments' adjusted operating margin of 46.1% is competitive, but it is important to compare this to specific peers to determine if it is above or below industry benchmarks.
Stakeholder Impact
- Shareholders will benefit from the share repurchase program and the potential value creation from the sale of AdvancedMD.
- Employees may experience changes due to the business transformation and the sale of AdvancedMD.
- Customers of AdvancedMD will be impacted by the change in ownership, but the company has established a long-term commercial partnership to ensure continuity.
- Suppliers and creditors may be affected by the company's strategic changes and capital allocation decisions.
Next Steps
- The company will complete the sale of AdvancedMD in the fourth quarter of 2024.
- The accelerated share repurchase program will be finalized by December 31, 2024.
- Global Payments will continue to execute its transformation agenda and focus on strategic priorities.
- The company will host a live audio webcast on October 30, 2024, to discuss financial results and business highlights.
Key Dates
| Date | Description |
|---|---|
| September 30, 2024 | End of the third quarter for which financial results are reported. |
| October 30, 2024 | Date of the press release announcing Q3 2024 results, the sale of AdvancedMD, and the share repurchase program. |
| October 31, 2024 | Expected date for the company to receive approximately five million shares under the accelerated share repurchase program. |
| December 13, 2024 | Record date for the dividend payment. |
| December 27, 2024 | Payment date for the dividend of $0.25 per share. |
| December 31, 2024 | Expected final settlement date for the accelerated share repurchase program. |
Keywords
Global Payments, Financial Results, AdvancedMD, Share Repurchase, Earnings Per Share, Revenue, Divestiture, Francisco Partners, Payments Technology, Operating Margin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.